Literature DB >> 17989914

Atypical presentation of Guillain-Barre syndrome with acute hydrocephalus.

O Ozdemir1, T Calisaneller, E Sonmez, H Caner, N Altinors.   

Abstract

A 32-year-old man was treated with a ventriculo-peritoneal shunt for acute panventricular hydrocephalus. On the third postoperative day, an ascending tetraparesis and subsequent respiratory failure developed. Based on the clinical findings, cerebrospinal fluid study and electrophysiological results, a diagnosis of Guillain-Barre syndrome (GBS) was made. Despite plasmaphoresis and immunoglobulin infusion, the patient was ventilator dependent and bed-bound for 4 months. One year later, he was able to walk without assistance and had only slightly wasting of the intrinsic hand muscles. This is the first report of acute hydrocephalus preceding the symptoms of GBS.

Entities:  

Mesh:

Year:  2007        PMID: 17989914     DOI: 10.1007/s00701-007-1405-9

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  4 in total

1.  The Pseudotumor Cerebri Syndrome: A Unifying Pathophysiological Concept for Patients with Isolated Intracranial Hypertension with Neither Mass Lesion Nor Ventriculomegaly.

Authors:  G M Halmagyi; R M Ahmed; I H Johnston
Journal:  Neuroophthalmology       Date:  2014-07-24

2.  Case Report: Intracranial Hypertension Secondary to Guillain-Barre Syndrome.

Authors:  Christina Doxaki; Eleftheria Papadopoulou; Iliana Maniadaki; Nikolaos G Tsakalis; Konstantinos Palikaras; Pelagia Vorgia
Journal:  Front Pediatr       Date:  2021-01-20       Impact factor: 3.418

3.  Guillain-Barre syndrome presenting with severe hydrocephalus in a child.

Authors:  Mohammad Barzegar; Majid Malaki
Journal:  J Pediatr Neurosci       Date:  2013-05

Review 4.  Hydrocephalus in Guillain barre syndrome: A case report and review of the literature.

Authors:  Ammar Taha Abdullah Abdulaziz; Dong Zhou; Jin Mei Li
Journal:  Medicine (Baltimore)       Date:  2020-04       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.